Enterotoxigenic bacteroides fragilis

Enterotoxigenic bacteroides fragilis has been studied in 1 paper since 2026: none in people yet, 1 review; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, May 28, 2026: “Anti-ETBF = "Anti-aging"? Breaking the Microbial Loop of Human Mortality through Anti-Aging Vaccines”.

Exposure

1 paper studies it2 findingsUpdated

See all 1 papers on enterotoxigenic bacteroides fragilis

What did studies of enterotoxigenic bacteroides fragilis find?

2

Studies of enterotoxigenic bacteroides fragilis measured 2 outcomes: telomere attrition and E-CADHERIN.

Telomere attrition

upin humans1

1 study
  1. Enterotoxigenic bacteroides fragilis increases telomere attrition in humans (proposed fragipain-fragilysin cascade).

    “accelerates telomere attrition”

    Reviewproposed fragipain-fragilysin cascade

    Anti-ETBF = "Anti-aging"? Breaking the Microbial Loop of Human Mortality through Anti-Aging Vaccines

    Zenodo (CERN European Organization for Nuclear Research)Preprint

More on Telomere attrition

E-CADHERIN

downin humans1

1 study
  1. Enterotoxigenic bacteroides fragilis decreases E-CADHERIN in humans (proposed fragipain-fragilysin cascade).

    “permanently cleaves human E-cadherin barriers”

    Reviewproposed fragipain-fragilysin cascade

    Anti-ETBF = "Anti-aging"? Breaking the Microbial Loop of Human Mortality through Anti-Aging Vaccines

    Zenodo (CERN European Organization for Nuclear Research)Preprint

More on E-CADHERIN

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 1Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months